ENWhether stem cell therapy is legal in Germany sounds like a yes-or-no question, but the honest answer is “it depends on which one you mean”: three completely different things travel under that one name, and the law treats each of them differently.
This page separates what is forbidden, what is allowed and done every working day, and what is merely not forbidden — and why “not forbidden” does not mean “proven”. For the evidence itself, see stem cell treatment: what is proven and what is not.
Three different things behind one phrase
In law, “stem cells” means three different things: embryonic cells, blood stem cell transplants and licensed cell medicines. The first, embryonic stem cells, are taken from very early embryos; the whole German legal framework was built around them, and no clinic will offer them to a patient.
The second are haematopoietic, or blood-forming, stem cells — the patient’s own or a donor’s. This is the bone marrow transplant used in leukaemia, lymphoma and a number of inherited diseases: a routine, well worked-out procedure that health insurance pays for. See the page on bone marrow transplant in Germany.
The third are cell products licensed as medicines: CAR-T — the patient’s own immune cells reprogrammed to attack a tumour — and other advanced therapy medicinal products. Separate from these are commercial injections of “your own stem cells” for arthrosis, multiple sclerosis, autism or ageing: they are sold as therapy, but they hold no licence as a medicine.
What German law actually forbids
German law forbids deriving embryonic stem cells and allows work with existing cell lines only in research. The Embryo Protection Act (Embryonenschutzgesetz) of 1990 punishes with prison or a fine the use of a human embryo created outside the body for a purpose that does not serve its preservation, so embryonic stem cells cannot be derived on German soil. This is criminal law, and the ban concerns research, not treatment.
The Stem Cell Act (Stammzellgesetz) of 2002, amended in 2008, allows only existing embryonic cell lines, derived abroad before 1 May 2007, to be imported and used: in research only, only with a permit and only after review by the Central Ethics Committee for Stem Cell Research (ZES), which works at the Robert Koch Institute. Its role is described on the committee’s page at the Robert Koch Institute.
The conclusion deserves a plain sentence: there is no “embryonic stem cell clinic” for patients in Germany. A website offering such treatment is a reason to close the page.
What is allowed and happens every day
Every day, German hospitals transplant blood stem cells and use licensed cell medicines. Haematopoietic stem cell transplantation is the most common and best evidenced form of cell therapy. It sits under the Medicinal Products Act (Arzneimittelgesetz, AMG), while collecting the cells falls under the Transplantation Act (Transplantationsgesetz) when bone marrow is taken, or the Transfusion Act (Transfusionsgesetz) when they are collected from blood. It is carried out in university hospitals and specialised haematology centres.
Advanced therapy medicinal products are medicines. They are authorised centrally via the European Medicines Agency (EMA) under Regulation (EC) No 1394/2007, and in Germany the Paul Ehrlich Institute is the competent authority for them. A licensed product has a name, a marketing authorisation number and sharply defined indications, and its licence covers only those indications. The institute explains the procedure on its page on advanced therapy medicinal products.
At the clinic door, this is simple: if a clinic names a product and its licensed indication, the conversation is concrete; if all you hear is “stem cells”, there is nothing concrete to discuss.
The grey zone: clinical trials and the hospital exemption
The grey zone consists of two lawful routes: clinical trials and the hospital exemption. Taking part in a clinical trial is lawful and sometimes the only sensible route to a new method. A genuine trial has a registry number, a protocol and inclusion criteria, and treatment is free for the participant: the European Medicines Agency says clinical trials should never involve payment from the patient or their family. Being asked to pay for taking part is a warning sign in itself.
The hospital exemption is Section 4b of the Medicinal Products Act. It lets a clinic use an advanced cell product without a European licence if a doctor prescribes it as an individual preparation for one patient, it is not made routinely, and it is used in a specialised healthcare facility under a doctor’s responsibility. National permits are still needed: from the authority of the federal state for manufacturing, and from the Paul Ehrlich Institute for supplying the product to others. The clause is used in good faith but can also serve as legal cover for paid procedures, so ask exactly which basis the clinic is working on.
Five questions worth asking before paying
Before paying, get written answers to five questions. First: what exactly will be injected, and what is the product called in the paperwork? Second: on what legal basis is it used — a licensed medicine, a clinical trial or the hospital exemption? Third: which indication does the licence or permit name?
Fourth: who is responsible if something goes wrong, and where will you be followed up afterwards? Fifth: what does the contract say about the result? Words like rejuvenation, cartilage regrowth or halting the disease rarely appear in a contract and regularly appear in advertising. To see how the rules differ, compare the pages on stem cell clinics in Germany and on which country to choose for stem cell therapy.
Frequently asked questions
Is stem cell therapy legal in Germany?
Yes, within clear limits. Haematopoietic stem cell transplants, licensed advanced therapy medicinal products within their authorisation, clinical trials authorised by the regulators and the hospital exemption with national permits are lawful, and the Paul Ehrlich Institute is the competent German authority for these medicines. Deriving embryonic stem cells is forbidden, and existing lines may be imported for research only. Selling unlicensed cell products outside these routes could be breaking the law.
Can I be treated with embryonic stem cells in Germany?
No. The Embryo Protection Act forbids deriving these cells in Germany, and the Stem Cell Act allows existing lines to be imported only for research, only with a permit and after review by the Central Ethics Committee at the Robert Koch Institute. No German clinic will offer you such treatment. If someone offers it for money, close the website.
How can I check whether a cell product is licensed?
Ask the clinic for the product’s name and the indication it is used for, then check both with official sources such as the European Medicines Agency or the Paul Ehrlich Institute. A clinical trial must have a registry number; under the hospital exemption, the clinic should be able to name the German permit. If none of this gets a clear answer, that is an answer in itself.
How AlenMed checks an offer and arranges the trip
AlenMed checks the legal basis of an offer before arranging any trip. With the documents received, it asks the clinic for a written description of the procedure and its legal basis; if no clear answer comes back, it tells the patient so. For evidence-based indications, a partner clinic in the relevant field is found, an estimate and a visa invitation are prepared, and an interpreter works at the appointments.
AlenMed does not arrange treatment that has neither a licence nor a trial protocol behind it, however convincing the website looks. What is and is not proven in stem cell treatment is covered in the article stem cell treatment: what is proven and what is not.
This material is for information only. It is neither legal advice nor an offer, and treatment is decided by a doctor at an in-person consultation.